Clinical Trial

A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

Name: A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin — clinical trial record (NCT07215312)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to see how well LY3938577 works and how safe it is compared to degludec in people with type 2 diabetes. Participation in the study will last about 26 weeks.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-14

Trial Details

NCT Number	NCT07215312
Lead Sponsor	Eli Lilly and Company
Conditions	Diabetes Mellitus, Type 2
Enrollment	100 participants
Start Date	2025-10-13
Primary Completion	2026-11 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-13